With the expectation of new regulatory guidelines, and the need for increased productivity, companies will need to become “comfortable with data,” says Quintiles executive.
Recipharm will invest €40 in serialization equipment to ensure it can comply with evolving track and trace regulations in the US, Europe and other markets.
The global healthcare CRO market is expected to reach $45.2bn by 2022, according to a report by Grand View Research.
Suspension of operations at a French softgel facility reduced Catalent’s second quarter revenues by around $21m, but the firm expects full production to restart in March.
Safic-Alcan will sell chemicals used in the synthesis of antibiotics and APIs to drug ingredient firms in Italy under a new deal with Evonik.